141 related articles for article (PubMed ID: 37702141)
1. Effects of Skeleton Structure of Mesoporous Silica Nanoadjuvants on Cancer Immunotherapy.
Tan J; Ding B; Chen H; Meng Q; Li J; Yang C; Zhang W; Li X; Han D; Zheng P; Ma P; Lin J
Small; 2024 Jan; 20(3):e2305567. PubMed ID: 37702141
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
Nguyen TL; Choi Y; Kim J
Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
[TBL] [Abstract][Full Text] [Related]
3. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
4. Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment.
Huang Y; Nahar S; Alam MM; Hu S; McVicar DW; Yang D
ACS Nano; 2023 Oct; 17(20):19740-19752. PubMed ID: 37831945
[TBL] [Abstract][Full Text] [Related]
5. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
Lee JY; Kim MK; Nguyen TL; Kim J
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
7. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
[TBL] [Abstract][Full Text] [Related]
9. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
[TBL] [Abstract][Full Text] [Related]
10. Shape and Shear Stress Impact on the Toxicity of Mesoporous Silica Nanoparticles: In Vitro and In Vivo Evidence.
Cheng Y; Tao J; Zhang Y; Xi L; Han R; Xu M; Lee SM; Ge W; Gan Y; Zheng Y
Mol Pharm; 2023 Jun; 20(6):3187-3201. PubMed ID: 37167021
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
12. Modification of acrylic bone cement with mesoporous silica nanoparticles: effects on mechanical, fatigue and absorption properties.
Slane J; Vivanco J; Meyer J; Ploeg HL; Squire M
J Mech Behav Biomed Mater; 2014 Jan; 29():451-61. PubMed ID: 24211354
[TBL] [Abstract][Full Text] [Related]
13. Construction of selenium-embedded mesoporous silica with improved antibacterial activity.
Chen J; Wei Y; Yang X; Ni S; Hong F; Ni S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110910. PubMed ID: 32126358
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy.
Escriche-Navarro B; Escudero A; Lucena-Sánchez E; Sancenón F; García-Fernández A; Martínez-Máñez R
Adv Sci (Weinh); 2022 Sep; 9(26):e2200756. PubMed ID: 35866466
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
Djayanti K; Maharjan P; Cho KH; Jeong S; Kim MS; Shin MC; Min KA
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047329
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
18. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
19. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
20. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility.
Gounani Z; Asadollahi MA; Meyer RL; Arpanaei A
Int J Pharm; 2018 Feb; 537(1-2):148-161. PubMed ID: 29278732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
